MEK抑制剂相关视网膜病变的临床与形态学特征:与中心性浆液性脉络膜视网膜病变的差异
单中心回顾性队列纳入25例接受MEK抑制剂治疗转移性癌的患者共50眼、313个视网膜下液灶,用OCT系列评估液体形态、分布与脉络膜厚度;多数病灶双眼(92%)、多灶(77%)且累及中心凹(83.3%),液体消退时最佳矫正视力与基线无统计学差异,脉络膜厚度各时间点无统计学差异;作者认为这些特征可与中心性浆液性脉络膜视网膜病变鉴别。
要点
- 313个液灶分为穹顶形231个(73.8%)、毛毛虫形36个(11.5%)、波浪形31个(9.9%)、劈裂形15个(4.8%)。
- 全部液灶位于光感受器嵌合带与完整的视网膜色素上皮之间。
- 液体消退时最佳矫正视力与基线无统计学差异,无眼在积液时较基线下降超过2行Snellen视力。
核心结论
- MEK抑制剂相关的视网膜下液灶具有独特的临床与形态学特征,可与中心性浆液性脉络膜视网膜病变的所见相鉴别。
- 在本系列中,MEK抑制剂未导致不可逆的视力丧失或严重眼损害。
研究设计与样本
- 单中心、回顾性队列研究,纳入25例因转移性癌接受MEK抑制剂治疗、经OCT确认存在浆液性视网膜脱离的患者共50眼、313个液灶。
- 采用临床检查与OCT评估MEK抑制剂相关的视网膜下液,系列评估每眼液灶的形态、分布与位置,并在基线、积液时、液体消退时测量脉络膜厚度。
- 由两名独立观察者完成全部测量,统计分析用于相关观察者间结果并比较各时间点的脉络膜厚度与视力。
主要发现
- 多数患者液灶为双眼(92%)、多灶(77%),且至少1个液灶累及中心凹(83.3%)。
- 313个液灶分为4种形态:穹顶形231个(73.8%)、毛毛虫形36个(11.5%)、波浪形31个(9.9%)、劈裂形15个(4.8%)。
- 全部液灶位于光感受器嵌合带与完整的视网膜色素上皮之间。
- 液体消退时最佳矫正视力与基线无统计学差异,积液时无眼较基线下降超过2行Snellen视力;基线、积液时与液体消退时的脉络膜厚度无统计学差异。
- 观察者间脉络膜厚度测量(r = 0.97, P < 0.0001)与液灶形态分级(r = 0.97, P < 0.0001)呈强正相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the clinical and morphologic characteristics of serous retinal disturbances in patients taking mitogen-activated protein kinase kinase (MEK) inhibitors. PARTICIPANTS: A total of 313 fluid foci in 50 eyes of 25 patients receiving MEK inhibitors for treatment of their metastatic cancer, who had evidence of serous retinal detachments confirmed by optical coherence tomography (OCT). DESIGN: Single-center, retrospective cohort study. METHODS: Clinical examination and OCT were used to evaluate MEK inhibitor-associated subretinal fluid. The morphology, distribution, and location of fluid foci were serially evaluated for each eye. Choroidal thickness was measured at each time point (baseline, fluid accumulation, and fluid resolution). Two independent observers performed all measurements. Statistical analysis was used to correlate interobserver findings and compare choroidal thickness and visual acuity at each time point. MAIN OUTCOME MEASURES: Comparison of OCT characteristics of retinal abnormalities at baseline to fluid accumulation. RESULTS: The majority of patients had fluid foci that were bilateral (92%) and multifocal (77%) and at least 1 focus involving the fovea (83.3%). All fluid foci occurred between the interdigitation zone and an intact retinal pigment epithelium. The 313 fluid foci were classified into 4 morphologies, as follows: 231 (73.8%) dome, 36 (11.5%) caterpillar, 31 (9.9%) wavy, and 15 (4.8%) splitting. Best-corrected visual acuity at fluid resolution was not statistically different from baseline; and no eye lost more than 2 Snellen lines from baseline at the time of fluid accumulation. There was no statistical difference in the choroidal thickness between the different time points (baseline, fluid accumulation, and fluid resolution). A strong positive interobserver correlation was obtained for choroidal thickness measurements (r = 0.97, P < 0.0001) and grading of foci morphology (r = 0.97, P < 0.0001). CONCLUSION: The subretinal fluid foci associated with MEK inhibitors have unique clinical and morphologic characteristics, which can be distinguished from the findings of central serous chorioretinopathy. In this series, MEK inhibitors did not cause irreversible loss of vision or serious eye damage.
引用
- Francis JH, Habib LA, Abramson DH, et al. Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy. Ophthalmology. 2017. PMID: 28709702. doi:10.1016/j.ophtha.2017.05.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。